Matt Foehr

Matt Foehr has a diverse work experience spanning various roles and companies in the pharmaceutical industry. Matt is currently the Chief Executive Officer at OmniAb, Inc. since November 2022. Prior to that, they served as a Board Member at Viking Therapeutics from May 2014 onwards. From April 2011 to October 2022, they held the position of President and Chief Operating Officer at Ligand Pharmaceuticals. Matt was also a Board Member at Ritter Pharmaceuticals, Inc. from February 2015 to May 2020. Before that, they held several leadership roles at Stiefel, a GSK company, including Vice President and Head of Consumer Dermatology R&D from January 2010 to April 2011. Earlier in their career, they held senior positions at Stiefel Laboratories and Connetics Corporation in various areas such as global R&D operations, product development, supply chain technical services, and manufacturing.

Matt Foehr attended Santa Clara University from 1990 to 1994, but it is not known what degree or field of study they pursued during this time.